Altre lingue Merit Medical Systems, Inc.

Azioni

MMSI

US5898891040

Fornitura medica

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 16/01/2026			Variaz. 5gg	Var. 1 gen.
82,31 ^USD	+2,44%		-11,67%	-6,61%

14/01	Merit Medical Systems, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 04:30 PM
14/01	Merit Medical Systems punta alle acquisizioni	CI

Altre lingue

14/01	Merit Medical Systems to Seek Acquisitions
08/01	Merit Medical Reports Preliminary Q4 Revenue, Names New Board Chair
08/01	Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
08/01	Merit Medical Systems, Inc. Announces Earnings Guidance for Fourth Quarter Ended December 31, 2025
08/01	Merit Medical Systems, Inc. Appoints F. Ann Millner as Chair of the Board, Effective January 5, 2026
08/01	Merit Medical Systems Insider Sold Shares Worth $450,000, According to a Recent SEC Filing
23/12	Merit Medical to Participate at the J.P. Morgan Healthcare Conference
26/11	Merit Medical Systems Insider Sold Shares Worth $880,377, According to a Recent SEC Filing
25/11	Merit Medical Systems Insider Sold Shares Worth $2,182,750, According to a Recent SEC Filing
21/11	Merit Medical Systems Insider Sold Shares Worth $1,702,650, According to a Recent SEC Filing
13/11	Merit Medical provides update on US reimbursement and commercial strategies for Wrapsody cell-impermeable endoprosthesis
13/11	Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
13/11	Merit Medical Systems, Inc. Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY Cell-Impermeable Endoprosthesis
05/11	Merit Medical Systems, Inc. Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula Arm of the Wrapsody Arteriovenous Access Efficacy Trial
05/11	Merit Medical releases 24-month efficacy results from the randomized arteriovenous fistula (AVF) arm of the WRAPSODY arteriovenous access efficacy (WAVE) trial
05/11	Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
03/11	Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft Cohort of the Wrapsody Arteriovenous Access Efficacy Trial
03/11	Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
03/11	Merit Medical Systems, Inc. completed the acquisition of C2 CryoBalloon Product Line of Pentax of America, Inc.
30/10/25	Merit Medical: Q3 Earnings Snapshot
30/10/25	Merit Medical : Slide Deck
30/10/25	Medical devices maker Merit Medical's Q3 rev beats estimates on strength in cardiac intervention segment
30/10/25	Earnings Flash (MMSI) Merit Medical Systems, Inc. Reports Q3 Revenue $384.2M, vs. FactSet Est of $371.9M
30/10/25	Earnings Flash (MMSI) Merit Medical Systems, Inc. Posts Q3 Adjusted EPS $0.92 per Share, vs. FactSet Est of $0.83
30/10/25	Merit Medical Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Altre lingue Merit Medical Systems, Inc.

Azioni

MMSI

US5898891040

Fornitura medica

Altre lingue

Filtri